Anthropic is moving toward one of the largest technology IPOs on record, with a reported potential valuation of $1–$2 trillion and annualized revenue that has grown from a roughly $1 billion run rate in late 2024 to an estimated $65 billion three quarters into 2026. But the investment case extends beyond a growth curve—it also runs through Washington. From export controls on AI chips to the shifting regulatory posture toward frontier models, policy developments are increasingly a swing factor in how this story trades.
During this webinar, SVP of Equity Research, Angelo Zino, CFA, VP of Equity Research, Janice Quek, and Shawn Chang, Senior TMT Analyst, Washington Analysis, will bring together fundamental and regulatory perspectives on Anthropic ahead of its anticipated public debut.
Topics covered:
- Business model and revenue growth: Anthropic's business mix, revenue trajectory, and positioning relative to OpenAI and other frontier AI labs.
- Competitive landscape: What reported enterprise large language model market share gains signal about competition among frontier AI companies.
- Valuation and profitability: Frameworks for evaluating rapid revenue growth alongside significant compute and model-training costs.
- Regulatory and policy risks: Potential implications of AI-chip export controls, federal AI oversight, and state-level AI legislation over the next 12–24 months.
- Public sentiment and AI backlash: How public scrutiny and potential backlash could influence Anthropic's investment case.
- IPO catalysts and timeline: What investors should watch following an S-1 filing, including elections, agency rulemaking, and congressional action.
